Baicalein Improves Motor and Cognitive Impairment While Promoting Remyelination in Cuprizone-Exposed Mice Through Antioxidant Mechanism
Preprint
- 18 April 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease. Repetitive demyelination defeats remyelination and impairs axonal conduction thus resulting in the characteristic disabilities of MS. Therefore, reducing demyelination and promoting remyelination are key strategies for the prevention and treatment of MS. In searching for new drugs to treat MS, many traditional Chinese herbs are gaining increasing attention. In the present study, baicalein (BA) was comprehensively investigated, by examining its effects on the cuprizone (CPZ)-induced neuropathological changes and behavioral abnormalities which are reminiscent of the clinical symptoms of MS patients, and exploring the cellular and molecular mechanisms underlying the effects. Our in vivo experiments demonstrated that BA facilitates the recovery of motor and cognitive impairment in CPZ-exposed mice while promoting the remyelination process and inhibiting neuroinflammation in their brains. Underlying these protective effects, BA intervention prevented the nuclear factor erythroid 2-related factor 2 (NRF2) and its downstream antioxidant enzymes (HO-1, NQO1, and SOD2) from over activation, thereby maintaining the signal pathway at normal levels through its antioxidant actions. Our in vitro experiments provided evidence that both CPZ and H2O2 delay the development of oligodendrocyte (OL) lineage cells by damaging mitochondria of the cells and resulting in oxidative stress. In the absence of astrocytes and microglia, BA effectively prevented cultured OLs from development delay by scavenging ROS resulted from damaged mitochondria of the cells. The elucidation of these cellular and molecular mechanisms will prompt clinical application of more naturally derived compounds with antioxidant properties to treat patients with MS.Keywords
All Related Versions
This publication has 78 references indexed in Scilit:
- Oligodendrocyte progenitor cells differentiation induction with MAPK/ERK inhibitor fails to support repair processes in the chronically demyelinated CNSGlia, 2023
- Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cellsGlia, 2022
- N‐acetylcysteine attenuates the cuprizone‐induced behavioral changes and oligodendrocyte loss in male C57BL/7 mice via its anti‐inflammation actionsJournal of Neuroscience Research, 2017
- Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal modelGlia, 2016
- Cell type-specific Nrf2 expression in multiple sclerosis lesionsActa Neuropathologica, 2015
- Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple SclerosisJAMA Neurology, 2015
- Differential effects of antipsychotics on the development of rat oligodendrocyte precursor cells exposed to cuprizoneEuropean Archives of Psychiatry and Clinical Neuroscience, 2013
- The cuprizone animal model: new insights into an old storyActa Neuropathologica, 2009
- The Neurotoxic Effect of Cuprizone on Oligodendrocytes Depends on the Presence of Pro-inflammatory Cytokines Secreted by MicrogliaNeurochemical Research, 2006
- Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patientsAnnals of Neurology, 2006